The story of Sildenafil presents a interesting case for stakeholders in the medicinal sector. While initially a blockbuster success, generating billions, the exclusivity lapse and the subsequent arrival of generic https://pharma928733.bligblogging.com/42487892/sildenafil-and-big-pharma-a-speculative-play